Lactoferrin: An iron-binding antimicrobial protein against Escherichia coli infection

BioMetals

Volumn 24, Issue 4, 2011, Pages 585-594

  Yen, Chih Ching ^a,b   Shen, Chih Jie ^a   Hsu, Wu Huei ^b   Chang, Yi Hsin ^a   Lin, Hsin Tang ^c   Chen, Hsiao Ling ^d   Chen, Chuan Mu ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c SHIH CHIEN UNIVERSITY   (Taiwan)

^d DA YEH UNIVERSITY   (Taiwan)

Author keywords

Antimicrobial activity; E. coli infection; Host defense protein; Lactoferrin; Nosocomial infection; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; CD14 ANTIGEN; ENDOTOXIN; LACTOFERRAMPIN[265-284]; LACTOFERRICIN; LACTOFERRICIN[17-30]; LACTOFERRIN; PEPSIN A; POLYPEPTIDE ANTIBIOTIC AGENT; PROBIOTIC AGENT; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBODY PRODUCTION; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ADHERENCE; CANDIDA ALBICANS; CELLULAR IMMUNITY; DIGESTIVE SYSTEM; DIGESTIVE SYSTEM INJURY; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROINVASIVE ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HOSPITAL INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE MUCOSA; IRON BINDING CAPACITY; LACTOBACILLUS RHAMNOSUS; NEWBORN SEPSIS; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEPTIC SHOCK; URINARY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; IRON; LACTOFERRIN; MICROBIAL SENSITIVITY TESTS;

ANIMALIA; AVES; BACILLI (CLASS); CANDIDA ALBICANS; ESCHERICHIA COLI; FUNGI; NEGIBACTERIA; STAPHYLOCOCCUS AUREUS; SUS;

EID: 79960087671     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-011-9423-8     Document Type: Article

References (70)

1. JK Actor SA Hwang ML Kruzel 2009 Lactoferrin as a natural immune modulator Curr Pharm Des 15 1956 1973 19519436 10.2174/138161209788453202 1:CAS:528:DC%2BD1MXotFKht7k%3D
2. K Ando K Hasegawa K Shindo T Furusawa T Fujino K Kikugawa H Nakano O Takeuchi S Akira T Akiyama J Gohda J Inoue M Hayakawa 2010 Human lactoferrin activates NF-kappaB through the toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling FEBS J 277 2051 2066 20345905 10.1111/j.1742-4658.2010.07620.x 1:CAS:528:DC%2BC3cXlvFejtL8%3D
3. BJ Appelmelk YQ An M Geerts BG Thijs HA de Boer DM MacLaren J de Graaff JH Nuijens 1994 Lactoferrin is a lipid A-binding protein Infect Immun 62 2628 2632 8188389 1:CAS:528:DyaK2MXhsFemtg%3D%3D (Pubitemid 24157102)
4. J Artym M Zimecki M Paprocka ML Kruzel 2003 Orally administered lactoferrin restores humoral immune response in immunocompromised mice Immunol Lett 89 9 15 12946859 10.1016/S0165-2478(03)00102-0 1:CAS:528: DC%2BD3sXms1ymtrk%3D (Pubitemid 37304015)
5. JD Baumgartner MP Glauser JA McCutchan EJ Ziegler G van Melle MR Klauber M Vogt E Muehlen R Luethy R Chiolero 1985 Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid Lancet 2 59 63 2861523 10.1016/S0140-6736(85)90176-X 1:STN:280:DyaL2M3jvFGgtw%3D%3D (Pubitemid 15047505)
6. MJ Bonten H Grundmann 2003 Selective digestive decontamination and antibiotic resistance: a balancing act Crit Care Med 31 2239 2240 12973186 10.1097/01.CCM.0000080491.46005.3F (Pubitemid 37011708)
7. J Bryce C Boschi-Pinto K Shibuya RE Black 2005 WHO estimates of the causes of death in children Lancet 365 1147 1152 15794969 10.1016/S0140-6736(05) 71877-8 (Pubitemid 40417564)
8. MA Campos MA Vargas V Regueiro CM Llompart S Alberti JA Bengoechea 2004 Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides Infect Immun 72 7107 7114 15557634 10.1128/IAI.72.12.7107-7114.2004 1:CAS:528:DC%2BD2cXhtVGls7rP (Pubitemid 39552380)
9. C Camus E Bellissant V Sebille D Perrotin B Garo A Legras A Renault P Le Corre PY Donnio A Gacouin J Gohda J Inoue M Hayakawa 2005 Prevention of acquired infections in intubated patients with the combination of two decontamination regimens Crit Care Med 33 307 314 15699832 10.1097/01.CCM.0000152224.01949.01 (Pubitemid 40216542)
10. HL Chen YW Lai CC Yen YY Lin CY Lu SH Yang TC Tsai YJ Lin CW Lin CM Chen 2004 Production of recombinant porcine lactoferrin exhibiting antibacterial activity in methylotrophic yeast, Pichia pastoris J Mol Microbiol Biotechnol 8 141 149 16088216 10.1159/000085787 1:CAS:528:DC%2BD2MXntFSgu7Y%3D (Pubitemid 41202238)
11. PW Chen SP Ho CL Shyu FC Mao 2004 Effects of bovine lactoferrin hydrolysate on the in vitro antimicrobial susceptibility of Escherichia coli strains isolated from baby pigs Am J Vet Res 65 131 137 14974567 10.2460/ajvr.2004.65.131 1:CAS:528:DC%2BD2cXhs1Gmtbc%3D (Pubitemid 38312744)
12. HL Chen CC Yen CY Lu CH Yu CM Chen 2006 Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans J Agric Food Chem 54 3277 3282 16637685 10.1021/jf053031s 1:CAS:528:DC%2BD28Xjt1Kmtr4%3D (Pubitemid 43798197)
13. HL Chen YW Lai CS Chen TW Chu W Lin CC Yen MF Lin MY Tu CM Chen 2010 Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract Biometals 23 543 554 20148305 10.1007/s10534-010-9298-0
14. N Cimolai JE Carter BJ Morrison JD Anderson 1990 Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome J Pediatr 116 589 592 2181099 10.1016/S0022-3476(05)81609-9 1:STN:280: DyaK3c3gsVWlsQ%3D%3D (Pubitemid 20124157)
15. MA Croxen BB Finlay 2010 Molecular mechanisms of Escherichia coli pathogenicity Nat Rev Microbiol 8 26 38 19966814 1:CAS:528:DC%2BD1MXhsFWksLnK
16. AN de Araujo LG Giugliano 2001 Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells BMC Microbiol 1 25 11690544 10.1186/1471-2180-1-25
17. E de Jonge MJ Schultz L Spanjaard PM Bossuyt MB Vroom J Dankert J Kesecioglu 2003 Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial Lancet 362 1011 1016 14522530 10.1016/S0140-6736(03)14409-1 (Pubitemid 37186877)
18. IR de Oliveira AN de Araujo SN Bao LG Giugliano 2001 Binding of lactoferrin and free secretory component to enterotoxigenic Escherichia coli FEMS Microbiol Lett 203 29 33 11557136 10.1111/j.1574-6968.2001.tb10816.x (Pubitemid 32830989)
19. L Edde RB Hipolito FF Hwang DR Headon RA Shalwitz MP Sherman 2001 Lactoferrin protects neonatal rats from gut-related systemic infection Am J Physiol Gastrointest Liver Physiol 281 G1140 G1150 11668022 1:CAS:528: DC%2BD3MXos1ags7o%3D
20. CJ Fisher Jr. JM Agosti SM Opal SF Lowry RA Balk JC Sadoff E Abraham RM Schein E Benjamin 1996 Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The soluble TNF receptor sepsis study group N Engl J Med 334 1697 1702 8637514 10.1056/NEJM199606273342603 1:CAS:528: DyaK28XksVOmsLc%3D (Pubitemid 26193621)
21. H Flores-Villasenor A Canizalez-Roman M Reyes-Lopez K Nazmi M de la Garza J Zazueta-Beltran N Leon-Sicairos JG Bolscher 2010 Bactericidal effect of bovine lactoferrin, lfcin, lfampin and lfchimera on antibiotic-resistant staphylococcus aureus and Escherichia coli Biometals 23 569 578 20195887 10.1007/s10534-010-9306-4 1:CAS:528:DC%2BC3cXlvFegtLg%3D
22. LG Giugliano ST Ribeiro MH Vainstein CJ Ulhoa 1995 Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli J Med Microbiol 42 3 9 7739021 10.1099/00222615-42-1-3 1:CAS:528:DyaK2MXktFKmsb8%3D
23. SA Gonzalez-Chavez S Arevalo-Gallegos Q Rascon-Cruz 2009 Lactoferrin: structure, function and applications Int J Antimicrob Agents 33 e301 e308 10.1016/j.ijantimicag.2008.07.020
24. LA Haversen I Engberg L Baltzer G Dolphin LA Hanson I Mattsby-Baltzer 2000 Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice Infect Immun 68 5816 5823 10992490 10.1128/IAI.68.10.5816-5823.2000 1:CAS:528:DC%2BD3cXmvVGnsbY%3D
25. CM Hung SC Wu CC Yen MF Lin YW Lai YT Tung HL Chen CM Chen 2010 Porcine lactoferrin as feedstuff additive elevates avian immunity and potentiates vaccination Biometals 23 579 587 20237823 10.1007/s10534-010-9321-5 1:CAS:528:DC%2BC3cXlvFegt7w%3D
26. CM Hung CC Yeh HL Chen CW Lai MF Kuo MH Yeh W Lin MY Tu HC Cheng CM Chen 2010 Porcine lactoferrin administration enhances peripheral lymphocyte proliferation and assists infectious bursal disease vaccination in native chickens Vaccine 28 2895 2902 20153353 10.1016/j.vaccine.2010.01.066 1:CAS:528:DC%2BC3cXjvFChsr0%3D
27. TW Hutchens JF Henry TT Yip 1991 Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation Proc Natl Acad Sci USA 88 2994 2998 2014220 10.1073/pnas.88.8.2994 1:CAS:528:DyaK3MXisVejurw%3D (Pubitemid 21916546)
28. RN Jones 2001 Resistance patterns among nosocomial pathogens: trends over the past few years Chest 119 397S 404S 11171776 10.1378/chest.119.2-suppl.397S 1:CAS:528:DC%2BD3MXitFCis70%3D (Pubitemid 32163809)
29. M Kaito M Iwasa N Fujita Y Kobayashi Y Kojima J Ikoma I Imoto Y Adachi H Hamano K Yamauchi 2007 Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin J Gastroenterol Hepatol 22 1894 1897 17914966 10.1111/j.1440-1746.2007.04858.x 1:CAS:528:DC%2BD2sXhtlOltbzF (Pubitemid 47525086)
30. T Kawai S Akira 2007 Signaling to nf-kappab by toll-like receptors Trends Mol Med 13 460 469 18029230 10.1016/j.molmed.2007.09.002 1:CAS:528: DC%2BD2sXhtlajsbfI (Pubitemid 350086981)
31. Y Kawasaki S Tazume K Shimizu H Matsuzawa S Dosako H Isoda M Tsukiji R Fujimura Y Muranaka H Isihida 2000 Inhibitory effects of bovine lactoferrin on the adherence of enterotoxigenic Escherichia coli to host cells Biosci Biotechnol Biochem 64 348 354 10737192 10.1271/bbb.64.348 1:CAS:528: DC%2BD3cXhvVCjt7o%3D
32. WS Kim T Tanaka H Kumura K Shimazaki 2002 Lactoferrin-binding proteins in bifidobacterium bifidum Biochem Cell Biol 80 91 94 11908648 10.1139/o01-226 1:CAS:528:DC%2BD38XitlCnsbs%3D (Pubitemid 34194232)
33. WS Kim M Ohashi T Tanaka H Kumura GY Kim IK Kwon JS Goh K Shimazaki 2004 Growth-promoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp Biometals 17 279 283 15222478 10.1023/B:BIOM.0000027705.57430.f1 1:CAS:528:DC%2BD2cXjvFarurs%3D (Pubitemid 38987150)
34. JC King Jr. GE Cummings N Guo L Trivedi BX Readmond V Keane S Feigelman R de Waard 2007 A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants J Pediatr Gastroenterol Nutr 44 245 251 17255839 10.1097/01.mpg.0000243435.54958.68 1:CAS:528: DC%2BD2sXptFegtQ%3D%3D (Pubitemid 46175080)
35. ML Kruzel Y Harari D Mailman JK Actor M Zimecki 2002 Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice Clin Exp Immunol 130 25 31 12296849 10.1046/j.1365-2249.2002.01956.x 1:CAS:528:DC%2BD38XotlGhu7g%3D
36. ME Kuipers HG de Vries MC Eikelboom DK Meijer PJ Swart 1999 Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates Antimicrob Agents Chemother 43 2635 2641 10543740 1:CAS:528:DyaK1MXnt1Wrt70%3D (Pubitemid 29519541)
37. WJ Lee JL Farmer M Hilty YB Kim 1998 The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets Infect Immun 66 1421 1426 9529062 1:CAS:528:DyaK1cXitFCis7Y%3D (Pubitemid 128471499)
38. D Legrand K Vigie EA Said E Elass M Masson MC Slomianny M Carpentier JP Briand J Mazurier AG Hovanessian 2004 Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells Eur J Biochem 271 303 317 14717698 10.1046/j.1432-1033.2003.03929.x 1:CAS:528:DC%2BD2cXhtValsLg%3D (Pubitemid 38130458)
39. JM Ling AB Schryvers 2006 Perspectives on interactions between lactoferrin and bacteria Biochem Cell Biol 84 275 281 16936797 10.1139/o06-044 1:CAS:528:DC%2BD28Xpt1SmsL0%3D (Pubitemid 44341301)
40. E Llobet JM Tomas JA Bengoechea 2008 Capsule polysaccharide is a bacterial decoy for antimicrobial peptides Microbiology 154 3877 3886 19047754 10.1099/mic.0.2008/022301-0 1:CAS:528:DC%2BD1MXhsVChtw%3D%3D
41. C Longhi M Marazzato MP Conte V Iebba S Schippa L Seganti A Comanducci 2009 Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli J Antibiot (Tokyo) 62 109 111 1:CAS:528:DC%2BD1MXlt1SgtL8%3D
42. P Manzoni M Rinaldi S Cattani L Pugni MG Romeo H Messner I Stolfi L Decembrino N Laforgia F Vagnarelli, et al. 2009 Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial JAMA 302 1421 1428 19809023 10.1001/jama.2009.1403 1:CAS:528:DC%2BD1MXht1Cksr%2FK
43. E Moreno G Prats M Sabate T Perez JR Johnson A Andreu 2006 Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli J Antimicrob Chemother 57 204 211 16390858 10.1093/jac/dki468 1:CAS:528:DC%2BD28XovVGmtA%3D%3D (Pubitemid 43160159)
44. Murray PR, Rosenthal KS, Pfaller MA (2009) Medical microbiology, 6th edn. Mosby Elsevier, Philadelphia, pp 301-315
45. C Nappi GA Tommaselli I Morra M Massaro C Formisano C Di Carlo 2009 Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study Acta Obstet Gynecol Scand 88 1031 1035 19639462 10.1080/00016340903117994 1:CAS:528:DC%2BD1MXhtVensLfN
46. L Nebermann JR Dohler L Perlick 2001 Treatment of enterogenic endotoxinemia with lactoferrin in rats Langenbecks Arch Surg 386 146 149 11374048 10.1007/s004230000191 1:STN:280:DC%2BD3M3ptFSqtA%3D%3D (Pubitemid 32335794)
47. JC Nickel 2007 Urinary tract infections and resistant bacteria: highlights of a symposium at the combined meeting of the 25th international congress of chemotherapy (icc) and the 17th European congress of clinical microbiology and infectious diseases (eccmid), March 31-April 3, 2007, Munich, Germany Rev Urol 9 78 80 17592541
48. TJ Ochoa M Noguera-Obenza F Ebel CA Guzman HF Gomez TG Cleary 2003 Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli Infect Immun 71 5149 5155 12933858 10.1128/IAI.71.9.5149-5155. 2003 1:CAS:528:DC%2BD3sXntFOqsLg%3D (Pubitemid 37070758)
49. TJ Ochoa EL Brown CE Guion JZ Chen RJ McMahon TG Cleary 2006 Effect of lactoferrin on enteroaggregative E. coli (EAEC) Biochem Cell Biol 84 369 376 16936809 10.1139/o06-053 1:CAS:528:DC%2BD28Xpt1Smsbg%3D (Pubitemid 44341313)
50. TJ Ochoa E Chea-Woo M Campos I Pecho A Prada RJ McMahon TG Cleary 2008 Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children Clin Infect Dis 46 1881 1883 18462105 10.1086/588476
51. H Pennington 2010 Escherichia coli o157 Lancet 376 1428 1435 20971366 10.1016/S0140-6736(10)60963-4 1:CAS:528:DC%2BC3cXhtlenurbF
52. D Pittet P Eggimann B Rubinovitch 2001 Prevention of ventilator- associated pneumonia by oral decontamination: just another SDD study? Am J Respir Crit Care Med 164 338 339 11500329 1:STN:280:DC%2BD3MvlsVKntA%3D%3D (Pubitemid 32778195)
53. Salyers AA, Whitt DD (2002) Bacterial pathogenesis: a molecular approach, 2nd edn. ASM press, Washington, DC, pp 24-30
54. MS Sanchez JL Watts 1999 Enhancement of the activity of novobiocin against Escherichia coli by lactoferrin J Dairy Sci 82 494 499 10194666 10.3168/jds.S0022-0302(99)75259-8 1:CAS:528:DyaK1MXitVWjt7o%3D (Pubitemid 129542000)
55. K Shin K Yamauchi S Teraguchi H Hayasawa M Tomita Y Otsuka S Yamazaki 1998 Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157:H7 Lett Appl Microbiol 26 407 411 9717310 10.1046/j.1472-765X.1998.00358.x 1:CAS:528:DyaK1cXltlOlsLY%3D (Pubitemid 28327903)
56. PK Singh MR Parsek EP Greenberg MJ Welsh 2002 A component of innate immunity prevents bacterial biofilm development Nature 417 552 555 12037568 10.1038/417552a 1:CAS:528:DC%2BD38XktVehtLs%3D (Pubitemid 34595922)
57. M Tomita H Wakabayashi K Yamauchi S Teraguchi H Hayasawa 2002 Bovine lactoferrin and lactoferricin derived from milk: production and applications Biochem Cell Biol 80 109 112 11908633 10.1139/o01-230 1:CAS:528: DC%2BD38XitlCnsbY%3D (Pubitemid 34194235)
58. P Valenti G Antonini 2005 Lactoferrin: an important host defence against microbial and viral attack Cell Mol Life Sci 62 2576 2587 16261253 10.1007/s00018-005-5372-0 1:CAS:528:DC%2BD2MXhtlSms7vO (Pubitemid 41721231)
59. MI van der Kraan J Groenink K Nazmi EC Veerman JG Bolscher AV Nieuw Amerongen 2004 Lactoferrampin: a novel antimicrobial peptide in the n1-domain of bovine lactoferrin Peptides 25 177 183 15062998 10.1016/j.peptides.2003.12.006 (Pubitemid 38520047)
60. M Viejo-Diaz MT Andres JF Fierro 2004 Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity Antimicrob Agents Chemother 48 1242 1248 15047526 10.1128/AAC.48.4.1242-1248.2004 1:CAS:528: DC%2BD2cXjtVKqsr0%3D (Pubitemid 38405478)
61. JL Vincent 2003 Selective digestive decontamination: for everyone, everywhere? Lancet 362 1006 1007 14522525 10.1016/S0140-6736(03)14445-5 (Pubitemid 37186873)
62. LH Vorland SA Osbakk T Perstolen H Ulvatne O Rekdal JS Svendsen TJ Gutteberg 1999 Interference of the antimicrobial peptide lactoferricin b with the action of various antibiotics against Escherichia coli and staphylococcus aureus Scand J Infect Dis 31 173 177 10447328 10.1080/003655499750006236 1:CAS:528:DC%2BD3MXhsl2gt7Y%3D (Pubitemid 29355527)
63. SC Wu HL Chen CC Yen MF Kuo TS Yang SR Wang CN Weng CM Chen WT Cheng 2007 Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance J Agric Food Chem 55 4670 4677 17489602 10.1021/jf063759o 1:CAS:528:DC%2BD2sXltVKqsbo%3D (Pubitemid 46960891)
64. MA Yekta F Verdonck W Van Den Broeck BM Goddeeris E Cox D Vanrompay 2010 Lactoferrin inhibits E. coli O157:H7 growth and attachment to intestinal epithelial cells Vet Med 55 359 368
65. CC Yen CY Lin KY Chong TC Tsai CJ Shen MF Lin CY Su HL Chen CM Chen 2009 Lactoferrin as a natural regimen for selective decontamination of the digestive tract: recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonates from pathogenic challenge in the gastrointestinal tract J Infect Dis 199 590 598 19125673 10.1086/596212 1:CAS:528:DC%2BD1MXislClurc%3D
66. T Zagulski P Lipinski A Zagulska Z Jarzabek 1998 Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system Int J Exp Pathol 79 117 123 9709381 1:CAS:528:DyaK1cXjs12rsrc%3D (Pubitemid 28219192)
67. N Zavaleta D Figueroa J Rivera J Sanchez S Alfaro B Lonnerdal 2007 Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea J Pediatr Gastroenterol Nutr 44 258 264 17255841 10.1097/MPG.0b013e31802c41b7 1:CAS:528:DC%2BD2sXptFegug%3D%3D (Pubitemid 46188074)
68. EJ Ziegler JA McCutchan J Fierer MP Glauser JC Sadoff H Douglas AI Braude 1982 Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli N Engl J Med 307 1225 1230 6752708 10.1056/ NEJM198211113072001 1:STN:280:DyaL3s%2Fjs1OqsQ%3D%3D (Pubitemid 12001356)
69. M Zimecki J Artym G Chodaczek M Kocieba ML Kruzel 2004 Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils Inflamm Res 53 292 296 15241563 10.1007/s00011-004-1257-1 1:CAS:528:DC%2BD2cXms1eiu7g%3D (Pubitemid 38969359)
70. A Zullo V De Francesco G Scaccianoce G Manes C Efrati C Hassan G Maconi D Piglionica C Cannaviello C Panella S Morini E Ierardi 2007 Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study Dig Liver Dis 39 806 810 17644057 10.1016/j.dld.2007.05.021 1:CAS:528:DC%2BD2sXht1Glt7nL (Pubitemid 47215580)